InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Tiny Gems
Monday Apr 22, 2024 - 9:20 am

InvestorNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Enters SID Agreement for Base Resources Transformational Acquisition

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium, rare earth elements (“REEs”) and vanadium has executed a definitive scheme implementation deed (“SID”) with Base Resources Limited. According to the agreement, Energy Fuels has agreed to acquire 100% of the issued shares of Base Resources in consideration for 0.0260 Energy Fuels common shares and A$0.065 in cash; the transaction will be payable by…

Continue Reading

Friday Apr 19, 2024 - 10:45 am

InvestorNewsBreaks – Diamond Lake Minerals Inc. (DLMI), BOXABL Collaboration Spotlighted in Latest Proactive Interview

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens, has been featured in an interview with Proactive. DLMI CEO Brian J. Esposito joined Proactive’s Steve Darling to discuss the company’s long-term real estate vision and its collaboration with BOXABL, Inc., a modular home building company. In the interview, Esposito stated that DLMI’s announcement…

Continue Reading

Thursday Apr 18, 2024 - 10:48 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority in Alzheimer’s Research to Scientific Advisory Board

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is announcing that Dr. David G. Morgan, PhD, a renowned leader in neurodegenerative disease, has joined its scientific advisory board (“SAB”). The announcement noted that the addition reinforces the company’s commitment to advancing its INM-901 program in the treatment of Alzheimer’s disease. Dr. Morgan is the…

Continue Reading

Thursday Apr 18, 2024 - 10:13 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Research Published in “Journal of Medicinal Chemistry”

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation, psychedelic-based treatment options, is reporting that its research has been published in a prestigious biweekly, peer-reviewed publication. Titled “Synthesis and Structure-Activity Relationships of 2,5-dimethoxy-4-substituted phenethylamines and the discovery of CYB210010: A potent, orally bioavailable and long-acting serotonin 5-HT 2 receptor agonist,” the research manuscript has…

Continue Reading

Tuesday Apr 16, 2024 - 1:25 pm

InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Announces Reverse Stock Split Ratio Ahead of Merger

QSAM Biosciences (OTCQB: QSAM) previously announced that it will effectuate a reverse stock split of the issued and outstanding shares of QSAM’s common stock, par value $0.0001 per share, at a ratio in the range of 1:1000 to 1:2000, prior to the closing of the merger between the company and Telix Pharmaceuticals Limited (ASX: TLX) (OTC: TLPPF), under which Telix will acquire QSAM. On April…

Continue Reading

Monday Apr 15, 2024 - 1:18 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company advancing its lead drug candidate, Berubicin, along the pathway to potential regulatory approval and commercialization, recently appointed Amy Mahery to its board of directors. “A biotech commercialization leader, Ms. Mahery has built an illustrious career that spans more than 20 years. During this period, she has gained commercial expertise working with small and large companies in common…

Continue Reading

Thursday Apr 11, 2024 - 3:00 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Leveraging Strategic Integrations to Unlock Continued Opportunities

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process and freight logistics, continues to be a marketplace partner with Geotab, a prominent company in the technology and logistics industry. “Fr8Tech announced last September that it had integrated its Fr8App freight-matching platform with Geotab’s open application programming interface (‘API’). According to the company, this integration was intended…

Continue Reading

Thursday Apr 11, 2024 - 12:16 pm

InvestorNewsBreaks – N2OFF Inc. (NASDAQ: NITO), Subsidiary Announce Inset Strategy, Focus on Collaborating with Companies Looking to Reduce N2O Greenhouse-Gas Emissions

N2OFF (NASDAQ: NITO) (FSE: 80W) (formerly known as Save Foods Inc.), a pioneer agrifood tech company offering sustainable solutions for agriculture and plant-based food, and its subsidiary NTWO OFF Ltd., are focused on capturing market opportunities with established companies that are wanting to reduce N2O greenhouse-gas emissions in agriculture. As part of that focus, the company is implementing an inset monetizing strategy that includes collaborating…

Continue Reading

Wednesday Apr 10, 2024 - 10:54 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) to Present at Bloom Burton & Co. Healthcare Conference

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, announced that its CEO Doug Drysdale will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference. The event is slated to take place April 16-17 in Toronto, Ontario. Drysdale’s presentation will be webcast live at 1:30 p.m. ET…

Continue Reading

Wednesday Apr 10, 2024 - 9:29 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Discusses Medicare Reimbursement Approval for CARE Oral Medical Devices in Proactive Interview

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is spotlighted in a recent Proactive interview. During the interview, Vivos CEO Kirk Huntsman and Proactive host Steve Darling discuss the latest news from the company, which is the regulatory approval for Medicare reimbursement of oral medical devices designed for…

Continue Reading

Tuesday Apr 09, 2024 - 1:47 pm

InvestorNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Moves Closer to Industrialization of E-Motion(TM) Product

Vision Marine Technologies Inc. (NASDAQ: VMAR), a leader in electric marine propulsion, today announced a groundbreaking achievement in electric outboard propulsion, in collaboration with McLaren Engineering, a division of Linamar Corporation. Aligning with the fast-evolving electric market and the upcoming SAE J1228 outboard compliance standard, Vision Marine has revolutionized the measurement of rated power output with its E-Motion(TM) 180E Electric Powertrain Systems. Vision Marine and…

Continue Reading

Tuesday Apr 09, 2024 - 11:04 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Achieves Milestone with CARE Oral Medical Devices Gaining Approval for Medicare Reimbursement

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, has obtained all required regulatory approvals so that its CARE oral medical devices can be reimbursed by Medicare. Calling this a “milestone achievement,” the company noted that millions of Medicare beneficiaries can now use and be reimbursed for allowable charges…

Continue Reading

Tuesday Apr 09, 2024 - 9:29 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes on $3.2M Public Offering

Flora Growth (NASDAQ: FLGC), a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000-plus points of distribution around the world, has closed on an underwritten public offering. The offering, which was comprised of 1.7 million common shares, resulted in $3.23 million in gross proceeds for Flora Growth, before deductions. Flora Growth plans to use the funds from the…

Continue Reading

Thursday Apr 04, 2024 - 11:24 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Delivers Significant Growth to Top Line Revenue

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, is celebrating its 11th anniversary of its founding in 2013 with a total of 18 contracts for new business along with five renewal agreements valued at over $1 million. “Building on the success of its first Innovation Week and the recently announced 2023 Financial Performance Highlights, Knightscope delivers significant…

Continue Reading

Tuesday Apr 02, 2024 - 2:22 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives New Epilepsy, Anti-Viral Agent Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received three new patent awards. According to the announcement, the company was awarded two new patents in its epilepsy patent family; both awards were granted in the United States. The U.S. patents, which cover both swallowed capsules and dissolvable oral tablets, complement research indicating DehydraTECH-CBD has potential to decrease epileptic seizures in rodents…

Continue Reading

Tuesday Apr 02, 2024 - 11:17 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Enters Acquisition Agreement to Acquire Biodefense Vaccine Developer

Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, has signed a definitive arrangement agreement to acquire Appili Therapeutics Inc. (TSX: APLI) (OTCQX: APLIF). Appili is a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures. According to the agreement, Adivir Inc., a wholly owned subsidiary of Aditxt, will acquire all issued and outstanding Class A common shares…

Continue Reading

Monday Apr 01, 2024 - 11:50 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate in Upcoming Investor Events

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in two April investor conferences, including the MedInvest Biotech & Pharma Investor Conference and the 14th annual LD Micro Invitational. CNS Pharmaceuticals CEO John Climaco will present at the one-day MedInvest Biotech & Pharma Investor event,…

Continue Reading

Monday Apr 01, 2024 - 10:46 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces FTZ Filing as ‘Strategic Initiative’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has filed for Foreign Trade Zone (“FTZ”) status with the U.S. Department of Commerce; the company is filing for the status at its commercial vehicle manufacturing and assembly center in Tunica, Mississippi. According to the announcement, the company anticipates that FTZ status would provide key benefits, including the opportunity for improving company cash flow through…

Continue Reading

Monday Apr 01, 2024 - 10:18 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, FY 2023 Financial Report, Operational Update

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is reporting financial results and operating highlights for Q4 and full year 2023, for the period ended Dec. 31, 2023. The report noted that revenue came in at $3.2 million for Q4 2023 and $13.8 million for the full year;…

Continue Reading

Monday Apr 01, 2024 - 10:01 am

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Releases Year-End 2023 Financial Report, Business Update

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial-intelligence (“AI”) and machine-learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, is reporting on its financial and operating results for the year ended Dec. 31, 2023; the company also released a corporate update. The report noted POAI experienced a net loss of…

Continue Reading

Monday Apr 01, 2024 - 9:25 am

InvestorNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Releases Q4, FY 2023 Financial Report, Business Update

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is reporting on its financial and business results for the fourth quarter and full year ending Dec. 31, 2023. The financial report included full-year 2023 revenue of $13.1 million, a 76% increase over the prior year and an increase over the full-year 2023 revenue guidance as well as Q4 2023 product revenue of…

Continue Reading

Thursday Mar 28, 2024 - 2:38 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Capitalizing on ‘Overwhelming Interest’ to Focus on GLP-1 Applications of DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that it will focus on glucagon-like peptide 1 (“GLP-1”) applications of its patented DehydraTECH(TM) technology for diabetes and weight loss for the 2024 calendar year. “This comes hot on the heels of a successful, active year of R&D in 2023, a year that saw significant strides in developing its patented DehydraTECH…

Continue Reading

Thursday Mar 28, 2024 - 1:39 pm

InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference

Processa (NASDAQ: PCSA) is a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer. The company today announced that its CEO George Ng will present a corporate update at the MedInvest Biotech and Pharma Investor Conference being held on April 3 – 4, 2024, in New York City. In addition, Ng…

Continue Reading

Thursday Mar 28, 2024 - 12:04 pm

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q4, FY 2023 Financial Report, Operational Update

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on its fourth-quarter and full-year 2023 financial results; the company also releases a corporate and commercial update. Highlights of the report include $20.4 million full-year 2023 revenue, down from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the core business-to-business-to-consumer (“B2B2C”) revenue increased; B2B2C, employers and health…

Continue Reading

Wednesday Mar 27, 2024 - 10:23 am

InvestorNewsBreaks – Ideanomics Inc.’s (NASDAQ: IDEX) Solectrac Announces Strategic Reorganization

Solectrac, a leader in the electric tractor industry and a wholly owned subsidiary of Ideanomics (NASDAQ: IDEX), has announced a strategic reorganization and shift in its business model. According to the update, the California-based distributor of electric tractors, recognized as an innovator in regenerative agriculture through its B Corp certification, is refocusing its efforts from expanding its dealer/distributor network to prioritizing direct-to-consumer sales and partnering…

Continue Reading

Thursday Mar 21, 2024 - 2:38 pm

InvestorNewsBreaks – Diamond Lake Minerals Inc. (DLMI) CEO Discusses Potential of Tokenization of Assets in Proactive Interview

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens, has been featured in an interview with Proactive Investors. DLMI CEO Brian J. Esposito joined Proactive’s Stephen Gunnion to discuss the company’s pioneering role in the development of digital assets and SEC-registered security tokens. Esposito talked about the potential of tokenization of financial assets…

Continue Reading

Thursday Mar 21, 2024 - 12:15 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Continuing to Redefine Logistics Landscape with Innovative Solutions

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed, industry-leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has been Riisa’s trusted logistics supplier for over two years, facilitating cross-border exportations and enabling Riisa to move its products with ease and efficiency. In Fr8App’s continued focus on redefining the logistics landscape, it…

Continue Reading

Thursday Mar 21, 2024 - 11:58 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO to Present at the Upcoming 14th Annual LD Micro Invitational

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that it will be participating at the 14th Annual LD Micro Invitational at the Sofitel New York on Apr. 8-9, 2024. Lexaria CEO Chris Bunka will be presenting at the event, with his presentation scheduled to begin at 10:30 a.m. ET on Tuesday, Apr. 9. Bunka will discuss the company’s recent…

Continue Reading

Thursday Mar 21, 2024 - 9:54 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day Extension

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, has been granted an additional 180 days to comply with NASDAQ’s minimum bid price requirement for the continued listing on the NASDAQ Capital Market. InMed received a letter from the exchange notifying it of the extended deadline, which will now be Sept. 16, 2024. According to…

Continue Reading

Wednesday Mar 20, 2024 - 2:58 pm

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Laying Foundation for Sustainable Long-Term Growth

GEMXX (OTC: GEMZ), a mining and jewelry-making company, specializes in the mining of ammolite, a rare, opal-like gemstone that is only found on the eastern slopes of the Rocky Mountains in Southern Alberta. Last year, the company expanded into the mining of gold to complement the historical resources that undergird its jewelry production strategy. “On Feb. 13, the company reported product deliveries worth $1,051,374 at…

Continue Reading

Wednesday Mar 20, 2024 - 12:30 pm

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Stockholders Vote to Approve Proposed MeridianBet Group Acquisition

Golden Matrix (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, is moving forward on the acquisition of MeridianBet Group. According to the announcement, GMGI stockholders approved the terms of the merger, which included the issuance of shares of common stock. The transaction was initially announced in June 2023. The announcement reported that stockholders representing 32,406,412…

Continue Reading

Wednesday Mar 20, 2024 - 9:45 am

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Releases Info on $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into definitive agreements. The agreements are for the sale and issuance of 1,542,112 shares of common stock (or prefunded warrants in lieu thereof) of the company and warrants to purchase up to 1,542,112 shares of common stock; the stocks and warrants are offered at…

Continue Reading

Tuesday Mar 19, 2024 - 12:00 pm

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company today announced its entry into definitive agreements for the sale and issuance of 1,542,112 shares of its common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 1,542,112 shares of common stock at a combined offering price of $4.215…

Continue Reading

Friday Mar 15, 2024 - 3:55 pm

InvestorNewsBreaks – Diamond Lake Minerals Inc.’s (DLMI) Leadership in Tokenization of Real Estate Assets Spotlighted in Recent Article

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens, was featured in a recent Benzinga article. The piece discussed the tokenization of real estate assets and DLMI’s role as one of the companies leading this quiet revolution. According to the article, tokenization, which refers to the process of converting physical assets like real…

Continue Reading

Friday Mar 15, 2024 - 2:58 pm

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Poised for Opportunity in Burgeoning Indian Market

GEMXX (OTC: GEMZ), a leading mine-to-market company focused on mining and producing jewelry out of gold and ammolite, recently provided a positive outlook covering India’s burgeoning markets for colored gemstones and jewelry. “In the press release, GEMXX highlighted recent industry forecasts, which anticipate that the jewelry market in India will surge by US$21.54 billion between 2023 and 2027, representing an impressive CAGR of 5.54%. This…

Continue Reading

Thursday Mar 14, 2024 - 12:47 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience in the life sciences industry. Most recently, he served as…

Continue Reading

Thursday Mar 14, 2024 - 11:38 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Appoints Key Sales Personnel to Leadership

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced key personnel additions to support its commercial EV van and truck program. According to the announcement, the company has appointed Tyler Jordan as senior director of commercial sales, Matt Nevious as director of commercial sales and strategic accounts, and Jacob Frenning as director of commercial sales Mid-Atlantic. The new hires were a result…

Continue Reading

Wednesday Mar 13, 2024 - 2:09 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Update on US Government Ruling for Class 1 EV Cargo Vans

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update on the U.S. Customs and Border Protection (“CBP”) application for Class 1 EV cargo vans. According to the announcement, the CBP, on March 5, 2024, informed Rapid Response Defense Systems (“RRDS”) counsel that a final determination on the ruling request needs to be issued by the U.S. General Services Administration (“GSA”).…

Continue Reading

Tuesday Mar 12, 2024 - 12:52 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Q4 and FY 2023 Earnings Release, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, today announced that it will provide a business update and release its financial results for the fourth quarter and full year 2023 following the close of the market on Thursday, March 28, 2024. On that same day at 2:30 p.m. PT (5:30 p.m. ET), Cepton will hold a conference call and…

Continue Reading

Monday Mar 11, 2024 - 10:25 am

InvestorNewsBreaks — Diamond Lake Minerals Inc. (DLMI) CEO, Advisory Board Member Spotlighted in Recent Proactive Broadcast

Diamond Lake Minerals (OTC: DLMI), a multistrategy operating company offering traditional investors an entry point to the future of digital securities, was featured in a recent Proactive release. A tech-enabled platform, Proactive works to empower companies globally with a comprehensive investor engagement solution across their business lifecycle. During the interview, which was held on International Women’s Day, Diamond Lake Minerals CEO Brian J. Esposito and…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).